Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Agriculture
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- University / Academia / Research
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Mining
- Automobile & Ground Transport
- Domestic
- Retail
- Logistics
- Soil and Groundwater
- Manufacturing, Other
- Food and Beverage
- Energy
Disease Detection Suppliers Serving Estonia
98 companies found
based inEpsom, UNITED KINGDOM
Our goal is to transform animal health through data intelligence. We will create the first integrated biomarker, health microchip and activity monitor for pets and livestock, for real time remote health monitoring, early detection of disease, ...
based inTunis, TUNISIA
Our mission: Make smallholders dairy farmers more profitable , traceable and sustainable - one feature at a time ...
Rumination metrics and alerts ensure that you are always armed with clear insights to make the best decisions for your cows. Using a MooMe collar will reduce vet costs, boost your cow health and protect your herd. ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD™ test is an innovative new blood test intended for use in patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of ...
based inParsippany, NEW JERSEY (USA)
Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA ...
based inCharlestown, MASSACHUSETTS (USA)
Seven Bridges is the leading biomedical data company, specializing in software and data analytics to drive public and private healthcare research. We deliver end-to-end bioinformatic solutions including access to datasets, analytic workflows and ...
The representation of the human reference genome as a linear haploid DNA sequence poses limitations when trying to incorporate the known genetic diversity of human populations. This has led to the development of graph-based references, able to ...
based inMississauga, ONTARIO (CANADA)
Intrinsik Inc. is a private, employee owned company with over 20 years of experience in environmental and health consulting. We are recognized as a leader in toxicology, risk assessment, and risk management consultation in Canada and around the ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
based inSauerlach, GERMANY
LOEWE was established in 1988 as an independent, privately owned company. As one of the commercial pioneers in the plant disease detection sector, the company started with the distribution of antisera for ELISA detection of plant viruses, produced ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inLiège, BELGIUM
ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for the screening of rare, genetic, chronic or infectious metabolic diseases in human ...
The Immunomat™ is intended for neonatal screening laboratories performing between 400 and 1000 daily determinations. With a maximum capacity of 7 microplates, it optimizes the rate of the laboratory by allowing the processing of different ...
based inVancouver, WASHINGTON (USA)
Oasis Diagnostics® Corporation was founded to conceive, develop, and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on non-invasive specimens, particularly saliva or oral fluid. The Company’s ...
based inDowners Grove, ILLINOIS (USA)
Shared Imaging provides top-tier diagnostic imaging systems and services, optimizing MRI, PET/CT, CT, and Women's Health systems acquisition through innovative, cost-effective methods. Leveraging extensive expertise as owners, operators, and service ...
MRI technology is a non-invasive imaging method that generates detailed three-dimensional anatomical images without the use of ionizing radiation, making it ideal for disease detection, diagnosis, and treatment ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with ...
based inEngomi (Nicosia), CYPRUS
DSt is an expert developer and supplier of semiconductor and MEM’s sensor die & devices for instrumentation, signal detection and process control for global markets. DSt specialize in the manufacture of niche market detectors and sensors. We are a ...
based inSydney, AUSTRALIA
Uscom Limited (UCM) is an Australian founded, ASX listed innovative medical technology company specialising in development and global marketing of premium non-invasive cardiovascular and pulmonary medical devices. Uscom has a mission to demonstrate ...
The SpiroSonic Ultrasonic spirometer employs advanced multi-path ultrasound technology to deliver high-fidelity pulmonary function ...
based inMainz, GERMANY
Fuelled by Innovation: With a pioneering spirit and high technical expertise, ORGENTEC has become firmly established in medical diagnostics. Our employees’ talent and skills establish the basis for our success. At our headquarters in Mainz, Germany, ...
AMA-M2 is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against mitochondrial M2 subtype antigen in human serum or plasma. Anti-mitochondrial antibodies (AMA) are a heterogeneous group of ...
based inWroclaw, POLAND
Genomtec is a technology company operating in the field of clinical diagnostics. It was established in 2016 in Wroclaw, with a vision of international expansion based on a unique mobile genetic diagnostics platform utilizing a patented contactless ...
based inConcepción, CHILE
We are a Chilean biotech company that enables the availability of products and services that improve the quality of life for humans and animals worldwide. We have a team of professionals with over 12 years experience in development of applied ...
AHPND has a bacterial aetiology. It is caused by specific virulent strains of Vibrio parahaemolyticus. Acute hepatopancreatic necrosis disease (AHPND) is a serious disease that has caused severe damage and significant financial losses to the global ...
